Talaan ng Balanse (Quarterly)
Neraca Theravance Biopharma, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.
Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 93 | 81 | 114 | 205 | 121 | 90 | 94 | 87 | 419 | 298 | 188 | 106 | 72 | 40 | 54 | 46 | 23 | 38 | 111 | 282 |
| Change (%) | -12.67 | 39.95 | 79.76 | -40.75 | -25.91 | 4.90 | -7.50 | 379.47 | -28.76 | -37.06 | -43.73 | -32.11 | -44.84 | 36.14 | -13.91 | -49.56 | 61.68 | 192.65 | 154.87 | |
| Assets Current | 451 | 393 | 293 | 333 | 297 | 250 | 205 | 155 | 512 | 353 | 261 | 192 | 162 | 134 | 124 | 119 | 116 | 161 | 150 | 366 |
| Change (%) | -12.73 | -25.49 | 13.69 | -10.81 | -15.92 | -18.10 | -24.39 | 230.72 | -30.93 | -26.06 | -26.53 | -15.79 | -17.41 | -6.92 | -4.01 | -2.37 | 38.28 | -6.71 | 143.77 | |
| Assets | 512 | 469 | 375 | 429 | 403 | 375 | 355 | 361 | 763 | 607 | 539 | 447 | 414 | 382 | 371 | 362 | 356 | 354 | 344 | 426 |
| Change (%) | -8.42 | -20.03 | 14.43 | -6.09 | -7.02 | -5.19 | 1.52 | 111.63 | -20.44 | -11.34 | -17.07 | -7.40 | -7.64 | -2.80 | -2.50 | -1.64 | -0.55 | -2.99 | 24.00 | |
| Liabilities | 774 | 773 | 748 | 730 | 727 | 713 | 707 | 711 | 283 | 166 | 168 | 166 | 167 | 169 | 166 | 168 | 170 | 179 | 178 | 201 |
| Change (%) | -0.12 | -3.17 | -2.50 | -0.40 | -1.83 | -0.92 | 0.53 | -60.18 | -41.47 | 1.44 | -0.91 | 0.60 | 0.92 | -1.52 | 1.14 | 1.25 | 4.79 | -0.57 | 13.28 | |
| Equity | -262 | -304 | -373 | -300 | -324 | -339 | -351 | -350 | 481 | 442 | 371 | 280 | 246 | 213 | 205 | 194 | 186 | 176 | 166 | 225 |
| Change (%) | 16.14 | 22.87 | -19.52 | 7.73 | 4.63 | 3.80 | -0.47 | -237.38 | -8.07 | -16.13 | -24.40 | -12.15 | -13.46 | -3.82 | -5.46 | -4.15 | -5.45 | -5.45 | 35.46 | |
| Liabilities And Stock Equity | 512 | 469 | 375 | 429 | 403 | 375 | 355 | 361 | 763 | 607 | 539 | 447 | 414 | 382 | 371 | 362 | 356 | 354 | 344 | 426 |
| Change (%) | -8.42 | -20.03 | 14.43 | -6.09 | -7.02 | -5.19 | 1.52 | 111.63 | -20.44 | -11.34 | -17.07 | -7.40 | -7.64 | -2.80 | -2.50 | -1.64 | -0.55 | -2.99 | 24.00 | |
Source: Capital IQ
